US7033951036 - Common Stock - After market: 30.59 0 (0%)
The two years away from the “chair” could cynically boost these oral health plays.
Becton Dickinson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82.
Patterson Cos. (PDCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Patterson Companies' (PDCO) fiscal second-quarter 2022 results benefit from strength in the Animal Health segment.
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 16% and 4.24%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.